Guest guest Posted November 21, 2008 Report Share Posted November 21, 2008 I think this article is suspect. They indicate that it could be beneficial to Type 1's and 2, but researching the pharmaceutical website, it is geared to those with pre-diabetic conditions, and glucose intolerance, perhaps meaning resistance? which are type 2s of course. In the case of Type 1s, diabetes is not typically about insulin resistance. *quote from Generex website* We are looking forward to conducting this trial and await the results with great interest, " said Prof. Paolo Pozzilli of University Campus Bio-Medico. " While it is not yet known whether the treatment of IGT (Impaired Glucose Tolerance) can delay or prevent diabetes or associated diseases such as cardiovascular disease, the delay of onset for high risk people will itself provide benefit in terms of morbidity and complications associated with the disease. We look forward to determining if the introduction of Generex Oral-lyn, as a non-injectable alternative, in the pre-diabetes state can play a role in empowering people to control daily glucose levels. " *end quote I'd like to ask them non-injectable alternative to what? In the pre-diabetes state, patients are typically not on meds or insulin. And besides, pills such as metformin are already non-injectable oral medications... aren't they? How is this oral insulin taken by mouth different? Those on insulin are not the same people as those with pre-diabetes. Also, when I googled about these supposed drug trials, one should find references to trials as these trials are in stage 3, and must have been around for a while. I could not find any reference to trials that are underway, even in the recent past. All results are from the Generex website, or pharmalive website, which is clearly a Generex website as well. I guess all I'm saying is before one jumps on this bandwagon, to proceed cautiously, and, in fact, if you can, refrain from proceeding at all. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 21, 2008 Report Share Posted November 21, 2008 Good observation! You might just be right! Dave God doesn't hate sinners, just sin! Re: new oral insulin I think this article is suspect. They indicate that it could be beneficial to Type 1's and 2, but researching the pharmaceutical website, it is geared to those with pre-diabetic conditions, and glucose intolerance, perhaps meaning resistance? which are type 2s of course. In the case of Type 1s, diabetes is not typically about insulin resistance. *quote from Generex website* We are looking forward to conducting this trial and await the results with great interest, " said Prof. Paolo Pozzilli of University Campus Bio-Medico. " While it is not yet known whether the treatment of IGT (Impaired Glucose Tolerance) can delay or prevent diabetes or associated diseases such as cardiovascular disease, the delay of onset for high risk people will itself provide benefit in terms of morbidity and complications associated with the disease. We look forward to determining if the introduction of Generex Oral-lyn, as a non-injectable alternative, in the pre-diabetes state can play a role in empowering people to control daily glucose levels. " *end quote I'd like to ask them non-injectable alternative to what? In the pre-diabetes state, patients are typically not on meds or insulin. And besides, pills such as metformin are already non-injectable oral medications... aren't they? How is this oral insulin taken by mouth different? Those on insulin are not the same people as those with pre-diabetes. Also, when I googled about these supposed drug trials, one should find references to trials as these trials are in stage 3, and must have been around for a while. I could not find any reference to trials that are underway, even in the recent past. All results are from the Generex website, or pharmalive website, which is clearly a Generex website as well. I guess all I'm saying is before one jumps on this bandwagon, to proceed cautiously, and, in fact, if you can, refrain from proceeding at all. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 24, 2008 Report Share Posted November 24, 2008 Oh wow! This sounds great! I wonder how long it will take to reach the States and Canada? Couldn't be too soon for me. To keep spiritually fit, consult the Great Physician. Love and hugs, and the furry ones. new oral insulin Generex Launches Oral Insulin for Diabetes Management Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India. Generex Biotechnology Corporation the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and Shreya Life Sciences Pvt. Ltd., the Company's importation, marketing and distribution licensee in India and the fourth largest marketer of insulin in India, jointly announced last Friday, the launch of commercial retail sales of Generex Oral-lyn in India. Generex Oral-lyn is approved in India for the treatment of adults and children with Type 1 and Type 2 diabetes and will be marketed and sold in India under the brand name " Oral-Recosulin " . Shreya will offer the product through its sales force of more than 1,000 people and will implement a continuing medical education program to introduce the product to endocrinologists, diabetologists and physicians in India and expects that the product will eventually be available in more than 2,500 pharmacies in the country. The launch of Oral-Recosulin, which offers a simple, convenient, fast, effective, flexible, familiar and pain-free alternative to prandial injections of insulin, coincides with the United Nations' World Diabetes Day, celebrated annually on November 14. The product is expected to be widely available for retail purchase in India before the end of the month. " It is with great anticipation and enthusiasm that we launch this innovative new product for the Indian diabetes market. Diabetes is reaching epidemic proportions in India, with over 40.8 million diagnosed patients and an estimated 35.9 million additional people with pre-diabetic conditions which, if not properly treated and managed, could lead to full-blown diabetes, " said Sujit Kumar Singh, the Chairman & Managing Director of Shreya. " Early intervention with insulin therapy could delay the onset and progression of diabetes and its numerous complications. Generex Oral-lyn, as a convenient and pain-free alternative to prandial insulin injections, could encourage insulin therapy among those patients who presently avoid injections. We look forward to our collaboration with Generex to revolutionize the treatment of diabetes in India. " Generex Oral-lyn is Generex's flagship product, a proprietary oral insulin spray that has been approved in India by the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, for importation, commercial marketing and sale for the treatment of Type 1 and Type 2 diabetes. Generex Oral-lyn is the first non-injectable buccal insulin approved in India. Unlike inhaled insulin products, buccally absorbed Generex Oral-lyn does not have pulmonary side effects. Generex Oral-lyn is safely and efficiently delivered without pain via the Company's proprietary RapidMist device, which looks like a simple asthma inhaler, but provides complete absorption through the buccal mucosa (lining of the mouth) with no deposit in the lungs. =========================== Advertisement Dr. Bernstein's Secrets To Normal Blood Sugars. A five CD set containing personal education straight from Dr. Bernstein himself. Audio and Video, plus hours of seminars, transcripts, and more. Learn more here. http://www.diabetes911.net/secrets.php Send to Friend | Share | Print | Category | Home This article originally posted November 19, 2008 and appeared in Issue 443 Past five issues: Issue 443 | Issue 443 | Issue 442 | Issue 441 | Issue 440 | Have a comment? Post it here. Visit the NEW Diabetes In Control Blog. Click Here! There are no comments to this article at this time. Be the first! Top Ten Most Read Articles: A Spoonful of Vinegar Helps the Sugar Go Down Read: 40056 Times 5 Sample Meal Plans, from 1200 to 2200 calories, in English and Spanish Read: 18835 Times Diabetes 101 Read: 16058 Times New Type 3 Diabetes Discovered Read: 14845 Times Oral Insulin Spray (Oral-lyn) for Type 1 and 2 Diabetes in Ecuador Read: 14434 Times It's not just another glargine LevemirR Read: 11878 Times The GlucoBand-New Non-Invasive Continuous Blood Glucose Monitor- Read: 11653 Times Chili Extract A Possible Cure for Diabetes Read: 11159 Times Weight Training and Diabetes Read: 9599 Times Drugs in Development Read: 9395 Times See more most read... Browse by Feature Writer & Article Category A. Lee Dellon, MD | Beverly Price | Birgitta I. Rice, MS | Did You Know | Dr. Bernstein | Dr. Jakes, Jr. | Dr. Varon, DDS | Dr. Fred Pescatore | Dr. Walter Willett | Education | S. Freedland | Evan D. Rosen | Facts | Features | Ginger Kanzer- | Items for the Week | , MD | ph M. Caporusso | a Sandstedt | Plunkett | Leonard Lipson, M.A. | Lester A. Packer | Diane | New Products | Newsflash | Chous, M.A., OD | Philip A. Wood PhD | R. | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Studies | Test Your Knowledge | Theresa L. Garnero | Tools | Vickie R. Driver | M. Volpone | This Week's Blog | Press Releases | Search Articles On Diabetes In Control Article Title: and/or Description: imageField Diabetes In Control Sponsors aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview Flash movie start Learn More About T2D Treatment Options Sign up for our FREE Weekly Newsletter Current Issue Past Issue Diabetes In Control. News and Information for Medical Professionals News and Information for Medical Professionals Search Diabetes In Control http://www.diabetesincontrol.com/newsite_sept2008/DinCart/production%20art/b utnsearch.gif Current Spotlight Newsletter Current Spotlight Newsletter Spotlight Product Reviews Spotlight Product Reviews New Products New Products Archive Archive About Us About Us Contact Us Contact Us Advertising Advertising Current Studies Current Studies Previous Studies Previous Studies Request Insight Svcs Request Insight Svcs Newsflash Newsflash Diabetes News Diabetes News Features Features Feature Writers Feature Writers Past Newsletters Past Newsletters Continuing Education Continuing Education Test Your Knowledge Test Your Knowledge Tools for your Practice Tools for your Practice link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT Send to Friend | Share | Print | Category | Home This article originally posted November 19, 2008 and appeared in Issue 443 Generex Launches Oral Insulin for Diabetes Management Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India. Diabetes In Control Sponsors http://www.diabetesincontrol.com/aserver/adclick.php?n=a8e6d6c1 Flash movie end Print This Week's Newsletter Download This Week's Newsletter Newsletter is in Adobe format If you don't have Adobe Acrobat Reader, you can download it for Free here. Free CE Available CE Programs On Diabetes Available here alltop Learn More About T2D Treatment Options Sign up for our FREE Weekly Newsletter Current Issue Past Issue production art/butnsignup Privacy / Advertising With Us / Contact Us Entries (RSS News) Add us to your favorite news reader addtogoogle addtomsm addtomyyahoo Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 24, 2008 Report Share Posted November 24, 2008 Oh wow! This sounds great! I wonder how long it will take to reach the States and Canada? Couldn't be too soon for me. To keep spiritually fit, consult the Great Physician. Love and hugs, and the furry ones. new oral insulin Generex Launches Oral Insulin for Diabetes Management Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India. Generex Biotechnology Corporation the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and Shreya Life Sciences Pvt. Ltd., the Company's importation, marketing and distribution licensee in India and the fourth largest marketer of insulin in India, jointly announced last Friday, the launch of commercial retail sales of Generex Oral-lyn in India. Generex Oral-lyn is approved in India for the treatment of adults and children with Type 1 and Type 2 diabetes and will be marketed and sold in India under the brand name " Oral-Recosulin " . Shreya will offer the product through its sales force of more than 1,000 people and will implement a continuing medical education program to introduce the product to endocrinologists, diabetologists and physicians in India and expects that the product will eventually be available in more than 2,500 pharmacies in the country. The launch of Oral-Recosulin, which offers a simple, convenient, fast, effective, flexible, familiar and pain-free alternative to prandial injections of insulin, coincides with the United Nations' World Diabetes Day, celebrated annually on November 14. The product is expected to be widely available for retail purchase in India before the end of the month. " It is with great anticipation and enthusiasm that we launch this innovative new product for the Indian diabetes market. Diabetes is reaching epidemic proportions in India, with over 40.8 million diagnosed patients and an estimated 35.9 million additional people with pre-diabetic conditions which, if not properly treated and managed, could lead to full-blown diabetes, " said Sujit Kumar Singh, the Chairman & Managing Director of Shreya. " Early intervention with insulin therapy could delay the onset and progression of diabetes and its numerous complications. Generex Oral-lyn, as a convenient and pain-free alternative to prandial insulin injections, could encourage insulin therapy among those patients who presently avoid injections. We look forward to our collaboration with Generex to revolutionize the treatment of diabetes in India. " Generex Oral-lyn is Generex's flagship product, a proprietary oral insulin spray that has been approved in India by the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, for importation, commercial marketing and sale for the treatment of Type 1 and Type 2 diabetes. Generex Oral-lyn is the first non-injectable buccal insulin approved in India. Unlike inhaled insulin products, buccally absorbed Generex Oral-lyn does not have pulmonary side effects. Generex Oral-lyn is safely and efficiently delivered without pain via the Company's proprietary RapidMist device, which looks like a simple asthma inhaler, but provides complete absorption through the buccal mucosa (lining of the mouth) with no deposit in the lungs. =========================== Advertisement Dr. Bernstein's Secrets To Normal Blood Sugars. A five CD set containing personal education straight from Dr. Bernstein himself. Audio and Video, plus hours of seminars, transcripts, and more. Learn more here. http://www.diabetes911.net/secrets.php Send to Friend | Share | Print | Category | Home This article originally posted November 19, 2008 and appeared in Issue 443 Past five issues: Issue 443 | Issue 443 | Issue 442 | Issue 441 | Issue 440 | Have a comment? Post it here. Visit the NEW Diabetes In Control Blog. Click Here! There are no comments to this article at this time. Be the first! Top Ten Most Read Articles: A Spoonful of Vinegar Helps the Sugar Go Down Read: 40056 Times 5 Sample Meal Plans, from 1200 to 2200 calories, in English and Spanish Read: 18835 Times Diabetes 101 Read: 16058 Times New Type 3 Diabetes Discovered Read: 14845 Times Oral Insulin Spray (Oral-lyn) for Type 1 and 2 Diabetes in Ecuador Read: 14434 Times It's not just another glargine LevemirR Read: 11878 Times The GlucoBand-New Non-Invasive Continuous Blood Glucose Monitor- Read: 11653 Times Chili Extract A Possible Cure for Diabetes Read: 11159 Times Weight Training and Diabetes Read: 9599 Times Drugs in Development Read: 9395 Times See more most read... Browse by Feature Writer & Article Category A. Lee Dellon, MD | Beverly Price | Birgitta I. Rice, MS | Did You Know | Dr. Bernstein | Dr. Jakes, Jr. | Dr. Varon, DDS | Dr. Fred Pescatore | Dr. Walter Willett | Education | S. Freedland | Evan D. Rosen | Facts | Features | Ginger Kanzer- | Items for the Week | , MD | ph M. Caporusso | a Sandstedt | Plunkett | Leonard Lipson, M.A. | Lester A. Packer | Diane | New Products | Newsflash | Chous, M.A., OD | Philip A. Wood PhD | R. | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Studies | Test Your Knowledge | Theresa L. Garnero | Tools | Vickie R. Driver | M. Volpone | This Week's Blog | Press Releases | Search Articles On Diabetes In Control Article Title: and/or Description: imageField Diabetes In Control Sponsors aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview Flash movie start Learn More About T2D Treatment Options Sign up for our FREE Weekly Newsletter Current Issue Past Issue Diabetes In Control. News and Information for Medical Professionals News and Information for Medical Professionals Search Diabetes In Control http://www.diabetesincontrol.com/newsite_sept2008/DinCart/production%20art/b utnsearch.gif Current Spotlight Newsletter Current Spotlight Newsletter Spotlight Product Reviews Spotlight Product Reviews New Products New Products Archive Archive About Us About Us Contact Us Contact Us Advertising Advertising Current Studies Current Studies Previous Studies Previous Studies Request Insight Svcs Request Insight Svcs Newsflash Newsflash Diabetes News Diabetes News Features Features Feature Writers Feature Writers Past Newsletters Past Newsletters Continuing Education Continuing Education Test Your Knowledge Test Your Knowledge Tools for your Practice Tools for your Practice link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT Send to Friend | Share | Print | Category | Home This article originally posted November 19, 2008 and appeared in Issue 443 Generex Launches Oral Insulin for Diabetes Management Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India. Diabetes In Control Sponsors http://www.diabetesincontrol.com/aserver/adclick.php?n=a8e6d6c1 Flash movie end Print This Week's Newsletter Download This Week's Newsletter Newsletter is in Adobe format If you don't have Adobe Acrobat Reader, you can download it for Free here. Free CE Available CE Programs On Diabetes Available here alltop Learn More About T2D Treatment Options Sign up for our FREE Weekly Newsletter Current Issue Past Issue production art/butnsignup Privacy / Advertising With Us / Contact Us Entries (RSS News) Add us to your favorite news reader addtogoogle addtomsm addtomyyahoo Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 24, 2008 Report Share Posted November 24, 2008 Oh wow! This sounds great! I wonder how long it will take to reach the States and Canada? Couldn't be too soon for me. To keep spiritually fit, consult the Great Physician. Love and hugs, and the furry ones. new oral insulin Generex Launches Oral Insulin for Diabetes Management Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India. Generex Biotechnology Corporation the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and Shreya Life Sciences Pvt. Ltd., the Company's importation, marketing and distribution licensee in India and the fourth largest marketer of insulin in India, jointly announced last Friday, the launch of commercial retail sales of Generex Oral-lyn in India. Generex Oral-lyn is approved in India for the treatment of adults and children with Type 1 and Type 2 diabetes and will be marketed and sold in India under the brand name " Oral-Recosulin " . Shreya will offer the product through its sales force of more than 1,000 people and will implement a continuing medical education program to introduce the product to endocrinologists, diabetologists and physicians in India and expects that the product will eventually be available in more than 2,500 pharmacies in the country. The launch of Oral-Recosulin, which offers a simple, convenient, fast, effective, flexible, familiar and pain-free alternative to prandial injections of insulin, coincides with the United Nations' World Diabetes Day, celebrated annually on November 14. The product is expected to be widely available for retail purchase in India before the end of the month. " It is with great anticipation and enthusiasm that we launch this innovative new product for the Indian diabetes market. Diabetes is reaching epidemic proportions in India, with over 40.8 million diagnosed patients and an estimated 35.9 million additional people with pre-diabetic conditions which, if not properly treated and managed, could lead to full-blown diabetes, " said Sujit Kumar Singh, the Chairman & Managing Director of Shreya. " Early intervention with insulin therapy could delay the onset and progression of diabetes and its numerous complications. Generex Oral-lyn, as a convenient and pain-free alternative to prandial insulin injections, could encourage insulin therapy among those patients who presently avoid injections. We look forward to our collaboration with Generex to revolutionize the treatment of diabetes in India. " Generex Oral-lyn is Generex's flagship product, a proprietary oral insulin spray that has been approved in India by the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, for importation, commercial marketing and sale for the treatment of Type 1 and Type 2 diabetes. Generex Oral-lyn is the first non-injectable buccal insulin approved in India. Unlike inhaled insulin products, buccally absorbed Generex Oral-lyn does not have pulmonary side effects. Generex Oral-lyn is safely and efficiently delivered without pain via the Company's proprietary RapidMist device, which looks like a simple asthma inhaler, but provides complete absorption through the buccal mucosa (lining of the mouth) with no deposit in the lungs. =========================== Advertisement Dr. Bernstein's Secrets To Normal Blood Sugars. A five CD set containing personal education straight from Dr. Bernstein himself. Audio and Video, plus hours of seminars, transcripts, and more. Learn more here. http://www.diabetes911.net/secrets.php Send to Friend | Share | Print | Category | Home This article originally posted November 19, 2008 and appeared in Issue 443 Past five issues: Issue 443 | Issue 443 | Issue 442 | Issue 441 | Issue 440 | Have a comment? Post it here. Visit the NEW Diabetes In Control Blog. Click Here! There are no comments to this article at this time. Be the first! Top Ten Most Read Articles: A Spoonful of Vinegar Helps the Sugar Go Down Read: 40056 Times 5 Sample Meal Plans, from 1200 to 2200 calories, in English and Spanish Read: 18835 Times Diabetes 101 Read: 16058 Times New Type 3 Diabetes Discovered Read: 14845 Times Oral Insulin Spray (Oral-lyn) for Type 1 and 2 Diabetes in Ecuador Read: 14434 Times It's not just another glargine LevemirR Read: 11878 Times The GlucoBand-New Non-Invasive Continuous Blood Glucose Monitor- Read: 11653 Times Chili Extract A Possible Cure for Diabetes Read: 11159 Times Weight Training and Diabetes Read: 9599 Times Drugs in Development Read: 9395 Times See more most read... Browse by Feature Writer & Article Category A. Lee Dellon, MD | Beverly Price | Birgitta I. Rice, MS | Did You Know | Dr. Bernstein | Dr. Jakes, Jr. | Dr. Varon, DDS | Dr. Fred Pescatore | Dr. Walter Willett | Education | S. Freedland | Evan D. Rosen | Facts | Features | Ginger Kanzer- | Items for the Week | , MD | ph M. Caporusso | a Sandstedt | Plunkett | Leonard Lipson, M.A. | Lester A. Packer | Diane | New Products | Newsflash | Chous, M.A., OD | Philip A. Wood PhD | R. | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Studies | Test Your Knowledge | Theresa L. Garnero | Tools | Vickie R. Driver | M. Volpone | This Week's Blog | Press Releases | Search Articles On Diabetes In Control Article Title: and/or Description: imageField Diabetes In Control Sponsors aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview aserver/adview Flash movie start Learn More About T2D Treatment Options Sign up for our FREE Weekly Newsletter Current Issue Past Issue Diabetes In Control. News and Information for Medical Professionals News and Information for Medical Professionals Search Diabetes In Control http://www.diabetesincontrol.com/newsite_sept2008/DinCart/production%20art/b utnsearch.gif Current Spotlight Newsletter Current Spotlight Newsletter Spotlight Product Reviews Spotlight Product Reviews New Products New Products Archive Archive About Us About Us Contact Us Contact Us Advertising Advertising Current Studies Current Studies Previous Studies Previous Studies Request Insight Svcs Request Insight Svcs Newsflash Newsflash Diabetes News Diabetes News Features Features Feature Writers Feature Writers Past Newsletters Past Newsletters Continuing Education Continuing Education Test Your Knowledge Test Your Knowledge Tools for your Practice Tools for your Practice link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT link region type: RECT Send to Friend | Share | Print | Category | Home This article originally posted November 19, 2008 and appeared in Issue 443 Generex Launches Oral Insulin for Diabetes Management Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India. Diabetes In Control Sponsors http://www.diabetesincontrol.com/aserver/adclick.php?n=a8e6d6c1 Flash movie end Print This Week's Newsletter Download This Week's Newsletter Newsletter is in Adobe format If you don't have Adobe Acrobat Reader, you can download it for Free here. Free CE Available CE Programs On Diabetes Available here alltop Learn More About T2D Treatment Options Sign up for our FREE Weekly Newsletter Current Issue Past Issue production art/butnsignup Privacy / Advertising With Us / Contact Us Entries (RSS News) Add us to your favorite news reader addtogoogle addtomsm addtomyyahoo Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.